Proteome Sciences Plc (PRM.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 16 | 73 | 170 | 171 | N/A |
| Cost of Goods | 11 | 41 | 83 | 132 | N/A |
| Gross Profit | 5 | 32 | 87 | 39 | N/A |
| Operating Expenses | 5,891 | 4,367 | 6,304 | 3,913 | 2,038 |
| Operating Income | -5,886 | -4,335 | -6,217 | -3,874 | -2,038 |
| Interest Expense | 1 | 2 | 6 | 11 | 32 |
| Other Income | -1,462 | -1,319 | -1,113 | -561 | -3 |
| Pre-tax Income | -7,349 | -5,656 | -7,336 | -4,446 | -2,073 |
| Income Tax | -452 | -457 | -555 | -336 | -70 |
| Net Income Continuous | -6,897 | -5,199 | -6,781 | -4,110 | -2,003 |
| Minority Interests | N/A | N/A | N/A | N/A | 26 |
| Net Income | $-6,897 | $-5,199 | $-6,781 | $-4,110 | $-1,977 |
| EPS Basic Total Ops | -0.05 | -0.04 | -0.06 | -0.04 | -0.02 |
| EPS Basic Continuous Ops | -0.05 | -0.04 | -0.06 | -0.04 | -0.02 |
| EPS Diluted Total Ops | -0.05 | -0.04 | -0.06 | -0.04 | -0.02 |
| EPS Diluted Continuous Ops | -0.05 | -0.04 | -0.06 | -0.04 | -0.02 |
| EBITDA(a) | $-6,922 | $-5,125 | $-6,745 | $-4,065 | $-1,938 |